Test Bank for Psychopharmacology: Drugs, the Brain, and Behavior, 4th Edition by Jerrold S. Meyer, Andrew M. Farrar, Dominik Biezonski & Jennifer R. Yates | Chapters 1-20 | NCLEX®-Style Questions & Clinical Rationales | Neuroscience, Psychology & Nursing

INSTANT PDF DOWNLOAD—This is the official, comprehensive Test Bank for Psychopharmacology: Drugs, the Brain, and Behavior, 4th Edition by Jerrold S. Meyer, Andrew M. Farrar, Dominik Biezonski, and Jennifer R. Yates, ISBN 9781605359878. Published by Oxford University Press / Sinauer Associates (2023), this resource is perfectly aligned with the leading psychopharmacology textbook used in psychology, neuroscience, pharmacology, and advanced nursing programs nationwide. This test bank is the identical instructor resource used to create course examinations and is the most demanded study aid for students mastering the complex relationships between psychoactive drugs, their mechanisms of action, and behavioral effects while preparing for NCLEX-RN®, neuroscience exams, and graduate-level coursework . This verified test bank provides complete, chapter-by-chapter coverage of all 20 chapters with hundreds of exam-style questions including multiple-choice, select-all-that-apply (SATA), clinical scenario-based questions, and experimental design questions. Each question includes verified answers with detailed rationales explaining the correct answer and clarifying common misconceptions, along with cognitive level tags and textbook page references . COMPREHENSIVE TOPIC COVERAGE INCLUDES: Part I: Foundations of Psychopharmacology Chapter 1: Principles of Pharmacology: Pharmacokinetics vs. pharmacodynamics, drug absorption, distribution, metabolism, excretion, bioavailability, half-life, therapeutic index, dose-response relationships, blood–brain barrier, routes of administration, and drug-receptor interactions . Chapter 2: Structure and Function of the Nervous System: Neurons and glial cells, action potential propagation, synaptic transmission, neurotransmitter release, organization of the CNS and PNS, and major brain structures (limbic system, basal ganglia, prefrontal cortex) . Chapter 3: Chemical Signaling by Neurotransmitters and Hormones: Ionotropic vs. metabotropic receptors, second messenger systems, neurotransmitter synthesis and storage, reuptake and degradation, neuroendocrine signaling, and the HPA axis . Chapter 4: Methods of Research in Psychopharmacology: Animal models (face validity, construct validity), neuroimaging techniques (PET, fMRI, EEG), microdialysis, self-administration paradigms, conditioned place preference, optogenetics, and chemogenetics . Part II: Neurotransmitter Systems Chapter 5: Catecholamines: Dopamine, norepinephrine, epinephrine synthesis and pathways; receptor subtypes (D1-D5, alpha, beta); roles in reward, motivation, addiction, motor control, and attention . Chapter 6: Serotonin: Serotonin synthesis and pathways, receptor families (5-HT1-7), roles in mood, anxiety, sleep, appetite, and impulse control . Chapter 7: Acetylcholine: Cholinergic pathways, nicotinic vs. muscarinic receptors, roles in cognition, memory, muscle contraction, and autonomic function . Chapter 8: Glutamate and GABA: Glutamate as the primary excitatory neurotransmitter (NMDA, AMPA, kainate receptors); GABA as the primary inhibitory neurotransmitter (GABA-A, GABA-B receptors); roles in learning, memory, anxiety, and seizure disorders . Part III: Drugs of Abuse and Addiction Chapter 9: Drug Abuse and Addiction: Neurobiology of addiction, reward circuitry (mesolimbic dopamine pathway), tolerance, sensitization, withdrawal, and factors influencing addiction development . Chapter 10: Alcohol: Pharmacokinetics of ethanol, GABA-A receptor modulation, NMDA receptor inhibition, effects on neurotransmitter systems, alcohol use disorder, and withdrawal management . Chapter 11: The Opioids: Endogenous opioid system (endorphins, enkephalins, dynorphins), opioid receptors (mu, delta, kappa), opioid analgesics (morphine, heroin, fentanyl), tolerance, dependence, and overdose reversal (naloxone) . Chapter 12: Psychomotor Stimulants: Cocaine, amphetamine, methamphetamine, methylphenidate; mechanisms of action (dopamine transporter blockade/reversal), acute and chronic effects, and synthetic cathinones . Chapter 13: Nicotine and Caffeine: Nicotinic acetylcholine receptors, nicotine addiction, vaping/e-cigarettes; caffeine as an adenosine antagonist, mechanisms, and effects . Chapter 14: Marijuana and the Cannabinoids: Endocannabinoid system (CB1, CB2 receptors), THC and CBD pharmacology, acute and chronic effects, medical cannabis, and cannabinoid hyperemesis syndrome . Chapter 15: Hallucinogens, PCP, and Ketamine: LSD, psilocybin, mescaline mechanisms (5-HT2A agonism), PCP and ketamine as NMDA antagonists, and therapeutic applications of psychedelics . Chapter 16: Inhalants, GHB, and Anabolic-Androgenic Steroids: Volatile solvent abuse, GHB pharmacology, anabolic steroid effects on mood, aggression, and neurochemistry . Part IV: Pharmacotherapy of Psychiatric Disorders Chapter 17: Disorders of Anxiety and Impulsivity and the Drugs Used to Treat Them: Anxiety disorders (GAD, panic disorder, social anxiety, PTSD, OCD), anxiolytics (benzodiazepines, buspirone, SSRIs, SNRIs), and impulse control disorders . Chapter 18: Affective Disorders: Antidepressants and Mood Stabilizers: Major depressive disorder, bipolar disorder; antidepressant classes (SSRIs, SNRIs, TCAs, MAOIs, atypical antidepressants); mood stabilizers (lithium, valproate, carbamazepine, lamotrigine); mechanisms, side effects, and treatment algorithms . Chapter 19: Schizophrenia: Antipsychotic Drugs: Schizophrenia pathophysiology, dopamine hypothesis; first-generation antipsychotics (haloperidol, chlorpromazine) vs. second-generation antipsychotics (clozapine, risperidone, olanzapine); mechanisms, side effects (EPS, tardive dyskinesia, metabolic syndrome), and management . Chapter 20: Neurodegenerative Diseases: Parkinson's disease (levodopa/carbidopa, dopamine agonists, MAO-B inhibitors), Alzheimer's disease (cholinesterase inhibitors, memantine), Huntington's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis . DOCUMENT ACCESS: This test bank is available as an instant digital download (PDF) immediately upon purchase. Fully text-searchable, printable, and accessible anytime through your user account. Trusted by thousands of psychology, neuroscience, nursing, and pharmacology students for psychopharmacology course exams, NCLEX-RN® preparation, and mastering the essential concepts of drug action, brain function, and behavior .